EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Clinical Significance Unveiled: Understanding the Meaning of FACE‐Q Skin Cancer Scores for Improved Patient Care

Inge J Veldhuizen, Stephen W Dusza, Alyce Kuo, Abdullah Aleisa, Elliot Blue, Sushmita Adhikari, Umer Nadir, Kim Le, Soroush Kazemi, Adam V Sutton, Rajiv I Nijhawan, Daniel B Eisen und 6 weitere

Psycho-Oncology · 2024

DOI: 10.1002/pon.70009 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Psycho-Oncology, 2024. Verfasst von Inge J Veldhuizen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Division, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Mohs Surgery, Patient Reported Outcome Measures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The FACE‐Q Skin Cancer Module is a Patient‐Reported Outcome Measure (PROM) utilized to assess outcomes following facial skin cancer resection. However, the lack of Minimal Important Difference (MID) estimates hinders the interpretability of the PROM scores. This study established MID estimates for the four outcome scales from the FACE‐Q Skin Cancer Module using distribution‐based methods.

Methods

A prospective cohort study at four hospitals in the United States, enrolled participants who underwent Mohs Micrographic Surgery (MMS) for facial skin cancer between April 2020 and April 2022. Participants completed the Satisfaction with Facial Appearance, Appearance‐related Psychosocial Distress, Cancer Worry, and Appraisal of Scars scales at four time points: pre‐operatively, 2‐week, 6‐month, and 1‐year post‐surgery.

Results

A total of 990 patients participated in the study, with completion rates of 98.4% for the pre‐operative assessment, 70.8% at 2 weeks, 59.3% at 6 months, and 60.4% at 1 year. MID estimates, calculated using 0.2 standard deviation and 0.2 standardized response mean, were determined for the four scales. The mean MID estimates, based on a Rasch transformed score ranging from 0 to 100, were 5 for the Appraisal of Scars scale and 4 for the remaining three scales.

Conclusion

This multicenter study provides valuable MID estimates for the FACE‐Q Skin Cancer Module, specifically for the MMS patient population, enabling clinicians and researchers to better interpret scores, determine appropriate sample sizes, and apply the findings in clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMohs SurgeryPatient Reported Outcome MeasuresHumansMaleFemaleProspective StudiesMiddle AgedAgedCicatrixPatient SatisfactionAdultAged, 80 and overSurveys and QuestionnairesUnited StatesFacial NeoplasmsQuality of LifeClinical Relevance

Stichwörter der Autor:innen

Mohs micrographic surgeryminimal important differencepatient‐reported outcome

Autor:innen und Institutionen

  • Dermatology Division, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Dermatology, King Saud University, Riyadh, Saudi Arabia.
  • Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Dermatology, UC Davis, David, California, USA.
  • Department of Pediatrics, McMaster University, Hamilton, Canada.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Veldhuizen, I. J., Dusza, S. W., Kuo, A., Aleisa, A., Blue, E., Adhikari, S., Nadir, U., Le, K., Kazemi, S., Sutton, A. V., Nijhawan, R. I., Eisen, D. B., Rossi, A. M., Srivastava, D., Wysong, A., Nehal, K. S., Klassen, A. F., & Lee, E. H. (2024). Clinical Significance Unveiled: Understanding the Meaning of FACE‐Q Skin Cancer Scores for Improved Patient Care. Psycho-Oncology. https://doi.org/10.1002/pon.70009

Vancouver

Veldhuizen IJ, Dusza SW, Kuo A, Aleisa A, Blue E, Adhikari S, et al. Clinical Significance Unveiled: Understanding the Meaning of FACE‐Q Skin Cancer Scores for Improved Patient Care. Psycho-Oncology. 2024. doi:10.1002/pon.70009

BibTeX
@article{Veldhuizen2024,
  author = {Veldhuizen, Inge J and Dusza, Stephen W and Kuo, Alyce and Aleisa, Abdullah and Blue, Elliot and Adhikari, Sushmita and Nadir, Umer and Le, Kim and Kazemi, Soroush and Sutton, Adam V and Nijhawan, Rajiv I and Eisen, Daniel B and Rossi, Anthony M and Srivastava, Divya and Wysong, Ashley and Nehal, Kishwer S and Klassen, Anne F and Lee, Erica H},
  title = {Clinical Significance Unveiled: Understanding the Meaning of FACE‐Q Skin Cancer Scores for Improved Patient Care},
  journal = {Psycho-Oncology},
  year = {2024},
  doi = {10.1002/pon.70009}
}
Kostenlos starten →